0001179110-13-012478.txt : 20130801
0001179110-13-012478.hdr.sgml : 20130801
20130801173324
ACCESSION NUMBER: 0001179110-13-012478
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130730
FILED AS OF DATE: 20130801
DATE AS OF CHANGE: 20130801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERAVANCE INC
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508086000
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mammen Mathai
CENTRAL INDEX KEY: 0001421050
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 131003728
MAIL ADDRESS:
STREET 1: THERAVANCE,INC.
STREET 2: 901 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
edgar.xml
FORM 4 -
X0306
4
2013-07-30
0
0001080014
THERAVANCE INC
THRX
0001421050
Mammen Mathai
THERAVANCE, INC.
901 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
SVP, Research & Early Clin Dev
Common Stock
2013-07-30
4
S
0
7000
36.51
D
211705
D
DISPOSITIONS MADE PURSUANT TO A PLAN INTENDED TO COMPLY WITH RULE 10b5-1(c).
This transaction was executed in multiple trades at prices ranging from $36.16 to $37.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Heather M. Shane as Attorney-in-Fact
2013-08-01